Evidence map›Paper›PMID 34203290›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Scolicidal and Apoptotic Activities of 5-hydroxy-1, 4-naphthoquinone as a Potent Agent against

Masoud Moghadaszadeh, Mehdi Khayyati, Adel Spotin, Roghayeh Norouzi, Abdol Sattar Pagheh, Sonia M R Oliveira, Maria de Lourdes Pereira, Ehsan Ahmadpour

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Propofol Induces the Expression of Nrf2 and HO-1 inTropical medicine and infectious disease · 2023
    Article
  4. Article
  5. Editorial-Current Insights on Lipid-Based Nanosystems.Pharmaceuticals (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Masoud MoghadaszadehBiotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mehdi KhayyatiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Adel SpotinInfectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Roghayeh NorouziDepartment of Pathobiology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.ORCID 0000-0002-4393-2380
Abdol Sattar PaghehInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Sonia M R OliveiraCICECO-Aveiro Institute of Materials, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0002-0707-5203
Maria de Lourdes PereiraCICECO-Aveiro Institute of Materials, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0001-6703-7869
Ehsan AhmadpourImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0003-1202-6147

Funding

FCT UIDB/50011/2020 and UIDP/50011/2020
6 · The paper itself

Abstract

Cystic hydatid disease (CHD) is a zoonotic disease with different clinical stages caused by the larval stage of the cestode

Indexed as

apoptotic activityEchinococcus granulosusjuglonenanoliposomescolicidal

Identifiers

PMID34203290
PMCPMC8308472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.